Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • Glanbia raises 2026 forecast after strong first half

    Glanbia reported a strong first half with adjusted earnings per share of €0.8124 (+30% currency-adjusted) and revenue of €2.1bn (+7% currency-adjusted). Group EBITDA rose 14.1% currency-adjusted to €275.4m and the EBITDA margin improved to 13.2%. Drivers were strong demand for protein products, price stability at Optimum Nutrition and cost savings; management raised the full-year guidance for adjusted EPS to currency-adjusted growth of 17–20% and increased the transformation savings target to €70m per year by 2027. » More on de.investing.com


  • Glanbia cuts Tirlán representation and reduces board size

    The Tirlán Co-operative Society is reducing its representation on the Glanbia board from two directors to one. John Murphy and Bill Carroll will resign on 4 August 2026; Ger O’Brien will be appointed on 5 August 2026 as a Tirlán‑nominated non‑executive director. After the changes, the board will consist of ten directors (two executive, the chair and seven non‑executive, one of whom is from Tirlán). Glanbia reports no further matters requiring disclosure. » More on de.investing.com


  • Tirlán sells 12 million Glanbia shares for €257.6 million

    The Tirlán Co-operative Society has completed the sale of 12,000,000 ordinary shares in Glanbia for a total of around €257.6 million. 9,671,170 shares were sold to institutional investors via an accelerated bookbuild, and 2,328,830 shares were sold off‑market to Glanbia as part of an approved targeted buyback; the price for both transactions was €21.47 per share. After settlement (expected around 16 June 2026) and the cancellation of the shares acquired by the company, Tirlán will remain the largest shareholder with 31,548,762 ordinary shares; the cancellation will reduce issued ordinary shares to an expected 239,613,665 and will use €50 million of the ongoing €100 million buyback program. » More on de.investing.com


  • Glanbia: Tirlán to sell around 5% (approx. 12 million shares), Glanbia to buy up to €50m off-market

    The Tirlán Co-operative Society plans to sell about 12 million Glanbia shares (≈5% of capital) via an accelerated placement to institutional investors and an off-market sale to Glanbia of up to €50 million. The off-market purchase will be made under an already approved buyback programme and is conditional on completion of the placement; all shares acquired by Glanbia will be cancelled. The price for the off-market purchase will be based on the bookbuilding price; after completion Glanbia intends to disclose the number and price of the shares acquired. » More on de.investing.com


  • Glanbia launches buyback programme of up to €50 million

    Glanbia has launched a share buyback programme of up to €50 million, which starts today and runs until 30 September 2026. Shares acquired will be cancelled to reduce share capital; J&E Davy will execute purchases as principal within set parameters and will make buy decisions independently of the company, including during closed trading periods. The programme is part of an overall €100 million initiative and is being carried out under an existing shareholder authorisation that expires at the end of April 2026 and must be renewed for continuation. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, GLANBIA has already paid €0.45 in dividends. The last payout was in October.

Financials

In the last quarter, GLANBIA had revenue of €2.04bn and net profit of €150.71m

(EUR) June 2026
YoY
Revenue 2.04bn -
Gross profit 542.97m -
Net profit 150.71m -
EBITDA 273.2m -

Fundamentals

Metric Value
Market capitalization
€4.71bn
Number of shares
236.87m
52-week high/low
€25.60 - €13.30
Dividend yield
2.19%
Dividends TTM
€0.45
Beta
0.45
P/E ratio
21.74
PEG ratio
0.20
P/B ratio
2.71
P/S ratio
1.24

Company profile

Glanbia plc operates as a nutrition company worldwide. The company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels. It engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. In addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It operates a portfolio of brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT brands. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Name
GLANBIA
CEO
Hugh McGuire Finance
Headquarters Kilkenny, kk
Ireland
Website
IPO
04/01/2000
Employees 5,800

Ticker symbols

Exchange Symbol
London Stock Exchange
GLB.L
Pnk
GLAPF
Frankfurt
GL9.F
Düsseldorf
GL9.DU
London
GLB.L
München
GL9.MU
🍪

Parqet  uses cookies. Learn more